The Academy for Clinical Debates & Controversies in Medicine. Beijing, China November 12-15, 2009

Transcription

1 The Academy for Clinical s & Controversies in Medicine THE 3rd ASIA PACIFIC CONGRESS ON Beijing, China November 12-15, 2009 Sponsorship & Exhibition Prospectus A comprehensive Congress fully devoted to clinical debates and controversial issues in a wide spectrum of Obstetrics, Gynecology & Infertility. cogi@comtecmed.com

2 Dear Friends and Colleagues, WELCOME LETTER Since their inception a decade ago, COGI (Controversies in Obstetrics, Gynecology and Infertility) Congresses have been recognized as the leading meeting formats for clinical updates on the most pressing questions of the day. At COGI, physicians meet with outstanding experts in all areas of Obstetrics and Gynecology: Perinatology, menopause, endoscopy, oncology and infertility. The COGI World Congress is designed as an umbrella for the ever-growing number of subdisciplines of our profession. The program is especially planned to engage in controversial issues in all fields related to Obstetrics, Gynecology and Infertility. Change and development are the main features of the Asia Pacific area today. Some debates are especially meaningful for this part of the globe, while others are common world wide. This issue will be embarked upon in depth, and with care. COGI in Beijing, which will take place in November 12-15, 2009, is being organized with the support of the Asia Pacific Association of Gynecologic Endoscope (APAGE); Royal Thai Colleague of Obstetrics and Gynecology (RTCOG); Asia Oceana Federation Obstetrics Gynecology (AOFOC); Asia Pacific Menopausal Federation (APMF); Asia Pacific Initiative on Reproduction (ASPIRE); World Association of Perinatal Medicine (WAPM) and the Asian Pacific Organization for Cancer Prevention and Control (APOCP). Previous COGI Congresses have taken place in different locations in Europe, Asia and North America. COGI Congresses are most comprehensive, dealing with all the burning issues of our profession, and emphasise evidence-based discussions. We invite you to join us in what we believe will be outstanding scientific and social event in the city of Beijing. Prof. Z. Ben-Rafael Co-Chairpersons Prof. Z. Shoham 2

3 COMMITTEES Honorary Chairpersons Suwachai Intaraprasert President of the Royal Thai College of Obstetrics and Gynecology (RTCOG) J.H. Lang President of the Chinese Society of Ob/Gyn Co-Chairpersons Zion Ben Rafael Tao Duan Qi Yu Zeev Shoham Organizing Committee Elizabet Farrell President of APMF Pak Chung Ho President of AOFOG Tsuyomu Ikenoue President of FAOPS Shin Yong Moon President of ASPIRE Joo-Hyun Nam President of APAGE Murat Tuncer President of APOCP PC Wong Past President of ASPIRE Pong Mo Yuen Past President of APAGE 3

4 ENDORSEMENTS Asia Pacific Association of Gynecologic Endoscope (APAGE) Royal Thai Colleague of Obstetrics and Gynecology (RTCOG) Asia Oceana Federation Obstetrics Gynecology (AOFOC) Asia Pacific Menopausal Federation (APMF) Asia Pacific Initiative on Reproduction (ASPIRE) World Association of Perinatal Medicine (WAPM) Asian Pacific Organization for Cancer Prevention and Control (APOCP) Federation of Asia and Oceania Perinatal Societies (FAOPS) 4

5 PRELIMINARY SCIENTIFIC PROGRAM Infertility & ART Keynote Lectures Advances in Obstetrics, Gynecology and Infertility: Leaders' Views on the Future Major Changes are taking place over short periods: What does the future hold for our main subdisciplines? Fetomaternal Medicine: Prevention of premature delivery Gynecology: Menopausal treatments: What does the future hold? Infertility & ART: Reflecting on the future of in vitro maturation (IVM) Mild Stimulation for IVF Results of monofollicular stimulation per initiated cycle are too low, and dropout is too high to make it a viable option for routine IVF! Proposition: Results of modified natural cycles are good without the risk - this is the future of IVF! Opposition: Results are too low and dropout is too high to make it a viable option! Milder ovarian stimulation for IVF reduces aneuploidy in the human preimplantation embryo Minimal stimulation or IVM: Which procedure, what dosage, and for how long? Cryopreservation of Gametes and Ovaries The best clinical method for cryopreservation of oocytes and ovarian tissue has yet to be decided Human oocyte cryopreservation: Slow freezing or verification techniques Freezing whole human ovaries Freezing/drying of spermatozoa Freezing/drying of stem cells Autotransplantation of frozen human ovarian tissue and follicles Increasing Success Rate in ART? Can better laboratory techniques bring about a breakthrough in success rate? Can we improve IVF results with prenatal genetic screening? Yes / No What can be achieved by good-quality assurance? Noninvasive gamete and embryo assessment Can we identify the best oocytes by new immunological biomarkers? Clinical Aspects of ART Round Table Discussion Expert Opinion Questions Corpus luteum supplementation: Is it evidence-based? Is there a risk of cancer after ovarian stimulation? Decremental dose or chronic low dose of follicle-stimulating hormone (FSH) for WHO group 2 patients? Unexplained infertility: Does it exist? Does it matter? Do we need the addition of luteinizing hormone (LH) for ovarian stimulation? Risk of ovarian hyperstimulation syndrome (OHSS): is it a real problem? Minimal monitoring of ovarian stimulation: Is it safe? What is the best way to prevent multiple pregnancies? Intracytoplasmic sperm injection (ICSI) for all patients? Is the embryo transfer (ET) technique important? Assisted zona hatching: What is the evidence? The relative myth of single ET Why did the antagonist not replace the agonist? 5

6 Assessment of Ovarian Reserve Decreased ovarian reserve remains a common and frustrating condition despite years of experience. Can we evaluate and provide better treatment? FSH and anti-mullerian Hormone (AMH) or ultrasonography: Which is preferable for evaluation of ovarian reserve? AMH! Ultrasonography Polycystic Ovarian Syndrome (PCOS) PCOS is a risk factor for insulin resistance: Are all PCOS patients at risk? Should metformin be routinely used in all PCOS infertile patients? Pros: Metformin during stimulation improves pregnancy outcome Cons: The effect on noninsulinresistant patients is questionable Systemic review does not show consistent effect! Proposition: No treatment options for decreased ovarian reserve and low responders are effective. It is only cycleto-cycle variation that is of importance! Opposition: Better protocols will result in better pregnancy rates! Stem Cells for Reproductive and Regenerative Medicine What are the expectations? What is feasible? How far are we now in the understanding of endometrial stem cells? Treating anovulatory PCOS patients: What should be the first choice? Ovulation induction? Ovarian drilling? IVM Long-term risks of PCOS women: What proof do we have and what proofs we don't have? Surgery to Increase IVF Success Fibroids, uterine septum, endometrioma. The current dilemma is: Should we operate first, or operate when IVF fails? Can stem cells serve as a source of gametes? Reprogramming as a new approach to obtain patient-specific stem cells In-Vitro Maturation (IVM) Despite many improvements, IVM is still experimental: Risk-benefits and pitfalls should be clarified Endometriosis is not easily diagnosed or managed: Can we choose from the many therapeutic options? Proposition: IVF is the shortest and best way to achieve pregnancy in stage 3-4 endometriosis Opposition: Operative laparoscopy to contain the disease is the first step to success : Will IVM ever replace standard IVF? Yes: Results of IVM are comparable to standard IVF No: IVM does not offer any advantage over current IVF practice Does resection of uterine septum before IVF enhance pregnancy rate? Should all intramural fibroids be operated on before IVF? Optimization of the procedure Who should be offered IVM? Are poor or high-responders candidates? Endometrioma: Why is it so poorly managed? Survival and IVM of frozen immature eggs 6

7 Feto-Maternal Medicine Intrapartum Surveillance Is it possible to minimize the risk of intrapartum asphyxia? Round Table Discussion Questions How do we assess 'fetal reserve'? What is the evidence for intermittent vs. continuous monitoring? How do we assess acid-base status? What are the new monitoring technologies? Medicolegal implications Premature Labor Preterm labor is a major risk factor for prematurity: Can we accurately diagnose and treat it? Advanced cervical dilatation with bulging membranes in midpregnancy: The role of emergency cerclage Acute tocolysis: Do we have a choice? Tocolysis: Is it outdated? Should we use multiple doses of steroids? Complications of Pregnancy: Pre-eclampsia Can we decrease mortality and morbidity through early diagnosis and treatment of pre-eclampsia? Can we predict or prevent pre-eclampsia? Can we manage pre-eclampsia effectively without knowing the pathophysiology? Emergency Situation in Perinatology Life-threatening situation in obstetrics should be identified and treated early Uterine atony: What are the most effective steps before hysterectomy? Novo-7: The best mode for controlling bleeding associated with disseminated intravascular coagulopathy (DIC) Can we save patients with amniotic fluid embolism? Expert Opinion: Ultrasound (US) Screening for Anomalies Screening for anomalies with US is widely used, however many parts of the examination remain controversial Round Table Discussion Questions Nasal bone: Fact or myth? Can "family album" assist in prenatal US screening? What can be gained by combining transvaginal screening? (TVS) to transabdominal screening (TAS) in late (24 weeks) sonographic screening? Does intra-amniotic sludge predict preterm delivery? Can we agree on the definition of Dandy-Walker syndrome in ultrasonography? Early (14-16 weeks) or late (18-22 weeks) screening? Fetal meconium peritonitis: Fact or myth? Amniotic Band Syndrome: Fact or myth? US Screening for Anomalies II Cardiac anomalies can affect 1:200 low-risk patients; however, current recommendations are that only high-risk cases be screened. Are these valid? Proposition: ISOUG recommend that an echocardiogram be performed in high-risk cases, and between 18 and 20 weeks Opposition: An echocardiogram should be performed in all low-risk patients, and 99% can already be identified at weeks! What are the traps and tricks in performing "four chamber views"? Abnormal cardiac flows in early pregnancy: What is the significance? Early Screening for Nuchal Thickness (NT) NT is a cornerstone in early detection of anomalies; however, confusion exists regarding the next step when NT is increased Proposition: Chorionic Villus Sampling (CVS) is the next step following increased NT Opposition: CVS should be performed only if detailed screening for anomalies is negative 7

8 Should we combine the NT with the early US screening in weeks 14-16, or should there be two separate scans? Yes / No Potential Prevention of Preterm Delivery Preterm delivery continues to be the most important issue in perinatal medicine, yet no effective prevention is available Can nutrition reduce the risk of preterm delivery? Progesterone to prevent preterm delivery Do we offer intensive care to all regardless of gestational age? Menopause/Gynecology/Oncology & Family Planning Cervical Cancer and Human Papilloma Virus (HPV) Does vaccination mark the end of cervical cancer? Epidemiology of cervical cancer and other HPV diseases What is the difference between quadrivalent or bivalent HPV vaccine HPV-DNA typing has no role in the routine evaluation of the abnormal Papanicoleau (Pap) smear Pap smear: How often? What is the best technology? Guideline for categorization: Should colposcopy be a routine part of the pelvic examination? Hi-Tech Perinatal Care Can sophisticated management increase the quality of perinatal care? Can we perform antenatal neurological assessment? What can MRI add to antenatal assessment? Can intrapartum fetal assessment be improved? Laparoscopic Hysterectomy and Complications regarding safety and indications is still ongoing What is the preferred route for hysterectomy? Proposition: Most uteri can be removed by laparoscopy! Opposition: Most uteri can only be removed vaginally Counseling patients for hi-tech interventions The pros and cons of laparoscopic myomectomy The Breech Recent studies claim that vaginal breech delivery is unsafe: Lack of experienced obstetricians supports the conclusion! Breech delivery: What is new? It is proven beyond any doubt that vaginal breech delivery is unsafe! Proposition: Vaginal breech delivery is unsafe! All term breeches should be delivered by elective Caesarean section Opposition: Singleton vaginal breech delivery at term: Still a safe option External cephalic version in modern obstetrics: Risks vs. benefits? : Robots and simulators: Do they play a role in endoscopic surgery? Laparoscopic Oncology: Endometrial Cancer and Adnexal Mass Laparoscopy is a potent tool in advanced surgery, but the debate over safety and indications in patients with gynecological cancer still continues Adnexal mass First choice should be laparoscopy Laparotomy is the safest mode Endometrial cancer First choice should be by laparotomy First choice should be by laparoscopy 8

9 Laparoscopy Should endometriosis of the bowel be resected in patients desiring fertility? Pros / Cons Laparoscopic-Hysterectomy and Complications Is total laparoscopic supracervical hysterectomy safer and superior to total hysterectomy? Pros / Cons Laparoscopic access: What about safety? Hormone Therapy (HT) for Osteoporosis and Climacteric Symptoms No consensus exists concerning the first-line therapy and prevention of postmenopausal osteoporosis! Is there no alternative to HT for relieving symptoms? Proposition: HT is cost-effective and should remain the first-line therapy for prevention of postmenopausal osteoporosis Opposition: Since the development of selective estrogen receptor modulators (SERMs) and bisphosphonates, is HT no longer desirable for osteoporosis? HT and Cancer Risk The fear of cancer still dominates the decisions of physicians and patients regarding initiation and continuation of HT Proposition: Breast cancer risk is related to the recommended HT dose and regimen! Opposition: It is impossible to predict women in whom HT will not increase the risk for breast cancer, and in any event it is unrelated to the dose and regimen! For what period can HT be safely administered? Can we combine SERMs and HT? HT for the prevention of CVD WHI results indicating a deleterious effect of HT on CVS remain controversial HT and CVD: Can the starter effect be eliminated? HT and CVD: How can the therapeutic window be defined? HT: Is the low-dose concept appropriate for all organ systems? Risks of HT Can we identify women who will benefit from HT without increased risks? Breast cancer: Does the choice of progesterone influence the risk of breast cancer? Is it possible to predict the risk for coronary heart disease (CHD) in women taking HT? Is it possible to predict the risk for stroke in women taking HT? Proposition: The risk of thrombosis is related to the dose and regimen of HT Opposition: The risk of thrombosis is unrelated to the dose and regimen of HT 9

10 MAJOR SPONSORSHIP OPPORTUNITIES As outlined below, a number of opportunities for sponsorship are available. In addition to the individual benefits of each package, all Sponsors will be acknowledged on the official Congress Website and in the final Congress Program. CONTINUING MEDICAL EDUCATION (CME) APPROVED SYMPOSIUM 25,000 The Sponsor may donate an unrestricted grant to support an existing session or suggest a CME-approved session (1.5-2 hours) as part of the Scientific Program. The expenses of the Symposium s chairpersons and speakers (registration, accommodation and travel) will be the responsibility of the Sponsor. Symposium hall and standard audiovisual equipment Four complimentary registrations (for Symposium chairpersons and speakers) A 100-word sponsor/product profile will be published in the final Congress Program Exhibition space of 12 sq.m Additional space may be obtained at a special reduced price of 400 per sq.m Two complimentary registrations for exhibitors Additional exhibitor s registrations may be purchased at 350 per person One A4 page advertisement, full color, will be included in the final Congress Program The Sponsor's logo will be published on the Congress Website, providing a two-way link separate Sponsor Logo page The Sponsor's brochure will be inserted in the participants' bags SATELLITE SYMPOSIUM (NON-CME APPROVED) 35,000 The Sponsor may organize an industrial non-cme Satellite Symposium (1.5-2 hours) as part of the Scientific Program. Organizing Committee approval of the content and speakers is required. The date and time of the Symposium will be mutually agreed upon. The expenses of the Symposium s chairpersons and speakers (registration, accommodation and travel) will be the responsibility of the Sponsor. Symposium hall and standard audiovisual equipment Five complimentary registrations (for Symposium chairpersons and speakers) A 100-word sponsor/product profile will be published in the final Congress Program Approximately 16 sq.m exhibition space Additional space may be obtained at a special, reduced price of 400 per sq.m Two complimentary registrations for exhibitors Additional exhibitor s registrations may be purchased at 350 per person One A4 page advertisement, full color, will be published in the final Congress Program The Sponsor's logo will be published on the Congress Website, providing a two-way link separate Sponsor Logo page The Sponsor's brochure will be inserted in the participants bags 10

11 PRE/POST-CONGRESS SATELLITE SYMPOSIUM (NON-CME APPROVED) (This option is particularly suited for drug launching and other special events) 45,000 The Sponsor may organize an industrial non-cme approved Pre/Post-Congress Satellite Symposium, for 3-4 hours (or more) on Thursday (Nov. 12, 2009), before the official opening of the Congress, or on Sunday (Nov. 15, 2009) at the end of the Congress. The expenses of the Symposium s chairpersons and speakers (registration, accommodation and travel) will be the responsibility of the Sponsor. Symposium hall and standard audiovisual equipment Six complimentary registrations (for Symposium chairpersons and speakers) A 100-word sponsor/product profile will be published in the final Congress Program Approximately 20 sq.m exhibition space Additional space may be obtained at a special, reduced price of 400 per sq.m Two complimentary registrations for exhibitors Additional exhibitor's registration may be purchased at 350 per person One A4 page advertisement, full color, will be published in the final Congress Program The Sponsor's logo will be published on the Congress Website, providing a two-way link separate Sponsor Logo page The Sponsor's brochure will be inserted in the participants bags LUNCH 20,000 (per lunch) The Sponsor may subsidize in part a buffet lunch served on Friday, (Nov. 13, 2009) and/or on Saturday (Nov. 14, 2009). Four complimentary registrations (for the Sponsor s staff) The Sponsor's logo will appear on a special board at the lunch venue A 100-word sponsor/product profile will be published in the final Congress Program An A4 half-page advertisement, full color, will be published in the final Congress Program The Sponsor's logo will be published on the Congress Website, providing a two-way link separate Sponsor Logo page The Sponsor s brochure will be inserted in the participants' bags 11

12 OTHER SPONSORSHIP OPPORTUNITIES In addition to the major sponsorship opportunities, a range of other sponsorship packages is available to meet various needs. WELCOME RECEPTION 10,000 A Welcome Reception for all participants will be held on Thursday evening (Nov. 12, 2009) at the Congress venue. The Sponsor s logo will appear on a special board at the Welcome Reception venue A 100-word sponsor/product profile will be published in the final Congress Program An A4 half-page advertisement, full color, will be published in the final Congress Program separate Sponsor Logo page The Sponsor s brochure will be inserted in the participants' bags CONGRESS PROGRAM 10,000 The final Congress Program will include the Scientific Program and the Scientific Abstracts of the Congress. The Congress Program will be distributed to all participants and will be an invaluable reference book after the Congress One A4 page advertisement, full color, will be published on the back cover of the final Congress Program A 100-word sponsor/product profile will be published in the final Congress Program The Sponsor's logo will be published on the Congress Website providing a two-way link separate Sponsor Logo page E-POSTERS 5,000 An E-Poster is an electronic version of the traditional poster board. Posters will be displayed on monitor screens. The E-Poster will include text, figures as well as videos. Abstracts will be displayed as an electronic poster (e-poster) during the days of the Congress. The electronic version of the posters will be uploaded to a virtual conference library (VCL), where they can be viewed during and after the Congress for a period of time. Display Sponsor logo/information on screensaver Display Sponsor logo/information on screen background Distribute mouse pads and related promotional gifts The Sponsor will be acknowledged in the final Congress Program and the logo will appear on a separate Sponsor Logo page 12

13 FACULTY DINNER 10,000 A Faculty Dinner will be held for invited speakers of the Congress. The Sponsor s logo will appear on a special board at the Faculty Dinner venue separate Sponsor Logo page INTERNET CENTER 8,000 The Internet Center will be outfitted with Internet workstations for participants of the Congress to check their and stay updated in-between sessions. The sponsorship package provides: workstations, areas for corporate logo display, technical support, furniture, adequate space for the workstations and Internet set-up and connection. Display Sponsor logo/information on screensaver Display Sponsor logo/information on screen background Distribute mouse pads and related promotional gifts at the internet center The Sponsor will be acknowledged in the final Congress Program and the logo will appear on a separate Sponsor Logo page PARTICIPANTS BAGS The Sponsor will provide the participants Congress bags. provided-in-kind + 7,000 The Sponsor's brochure/s will be inserted in the participants' bags The Sponsor's logo will be published on the Congress Website, providing a two-way link separate Sponsor Logo page The Sponsor s logo will appear on a Special Board on site 13

14 CD-ROM 5,000 The CD-Rom will contain all of the Scientific Abstracts of the Congress and will be distributed to all the participants. The CD-Rom may include the Sponsor s logo. An exchange voucher (printed by the Sponsor) will be placed in the participants bags. Exclusive advertisement on the cover of the voucher Exclusive advertisement on the cover of the CD-ROM cover MINI POCKET PROGRAM: 3,000 A Mini Pocket Program will be distributed to all participants with their registration kits. The Sponsor s exclusive advertisement on the back cover of the Mini Pocket Program The Sponsor's logo will be published on the Congress Website, providing a two-way link separate Sponsor logo page TRANSLATION 3,000 (per hall per day) Simultaneous translation from English to any required language. The Sponsor s logo will appear on a special board in the hall The Sponsor's logo will be published on the Congress Website, providing a two-way link separate Sponsor logo page WRITING PADS AND PENS provided-in-kind + 3,000 The Sponsor will provide all participants with notepads and pens, which will be included in the participants bags. This can be an effective high-profile sponsorship opportunity for a drug launch or for immediate brand recognition. The notepads and pens will bear the Sponsor s company product/logo 14

15 CONGRESS LANYARD The Sponsor provides printed lanyards for the name badges The Congress provides printed lanyards for the name badges 3,000 6,000 The Sponsor/product name, logo or text printed on lanyards separate Sponsor logo page The Sponsor s logo will appear on a Special Board on site ASIA PACIFIC SPEAKER 3,000 The Sponsor may support in part the expenses of one or more invited Asia Pacific Speaker. Expenses include registration, accommodation and travel. A half-page advertisement, full color, will be published in the final Congress Program separate Sponsor logo page The Sponsor s brochure will be inserted in the participants bags EUROPEAN SPEAKER 4,000 The Sponsor may support in part the expenses of one or more invited European Speaker. Expenses include registration, accommodation and travel. An A4 half-page advertisement, full color, will be published in the final Congress Program separate Sponsor logo page The Sponsor s brochure will be inserted in the participants bags AMERICAN SPEAKER 5,000 The Sponsor may support in part the expenses of one or more invited American Speaker. Expenses include registration, accommodation and travel. An A4 half-page advertisement, full color, will be published in the final Congress Program separate Sponsor logo page The Sponsor s brochure will be inserted in the participants bags 15

16 PRIZES FOR OUTSTANDING ABSTRACTS 3,000 Six prizes of 500 each will be awarded to the six most outstanding abstracts/posters. The winners will be announced at the Congress and will appear on the Website after the Congress. The Sponsor s representatives will be invited to attend the prize-giving. separate Sponsor Logo page BROCHURE INSERT 2,000 A brochure provided by the Sponsor will be inserted in the participants bags, which will be distributed to all of the participants of the Congress. 16

17 GENERAL INFORMATION Venue Beijing, China Sponsorship and Exhibition contact ComtecMed 53, Rothschild Boulevard, PO Box 68 Tel Aviv, 61000, Israel Tel: Fax: COGI@comtecmed.com Website: Accommodation and Registration ComtecMed 53, Rothschild Boulevard, PO Box 68 Tel Aviv, 61000, Israel Tel: Fax: cogi@comtecmed.com Language The official language of the Congress is English. Liability and Insurance The organizer carries no liability whatsoever for injuries or damages involving persons and/or property during the Congress. Participants are advised to issue their own personal travel and health insurance for their trip. 17

18 INFORMATION FOR SPONSORS AND EXHIBITORS Exhibition A professional exhibition will be held at the Congress venue, in conjunction with the Congress. The floor plan has been designed so as to maximize the exhibitors exposure to the delegates. Coffee breaks will be held in this exhibition area. Exhibition Space Sponsors may obtain additional exhibition space at 300 per sq.m. Non-sponsors may obtain exhibition space at 700 per sq.m. The minimum booth size is 8 sq.m. (4x2 meters). Two complimentary registrations for exhibitors Additional exhibitor s registrations may be purchased at 350 per person A 100-word sponsor/product profile will be published in the final Congress Program Welcome Reception and lunch on Friday and Saturday for registered exhibitors Exhibitor s Technical Manual Cleaning service for public area and gangways 24-hour security Booth Scheme Rental This includes: Booth scheme frame, basic lighting, electrical socket (500 W) Fascia panel with standard lettering Please note that booth scheme rental does not include furniture, or cleaning. Furniture, cleaning and other services may be ordered at a later stage in accordance with the offers shown in the Technical Manual. Allocation of Exhibition Booths Space/booth allocation will be confirmed on a first-come first-served basis. Please view the exhibition floor plan on the Congress Website: Exhibitor Registration All exhibitors are required to be registered and will receive a badge displaying the exhibiting sponsor s name 18

19 ComtecMed Medical Congresses Fax: Rothschild Boulevard Tel: P.O. Box 58 COGI@comtecmed.com Tel Aviv 61000, Israel Website: 3 rd Asia Pacific Congress on Controversies in Obstetrics, Gynecology & Infertility SPONSORSHIP BOOKING FORM Company Name: Contact Name: Address: Post/Zip Code: Telephone: Country: Fax: Website: I would like to book the following sponsorship items: Sponsorship item Price Continuing medical education (CME) Approved Symposium 25,000 Satellite Symposium (Non-CME approved) 35,000 Pre/Post- Congress Satellite Symposium (Non-CME approved) 45,000 Lunch 20,000 Welcome Reception 10,000 Congress Program 10,000 E-Posters 5,000 Faculty Dinner 10,000 Internet Center 8,000 Participants Bags 7,000 CD-ROM 5,000 Mini/Pocket Program 3,000 Translation 3,000 Writing Pads and Pens 3,000 Lanyards (sponsor provides) 3,000 Lanyards (congress provides) 6,000 Asia Pacific Speaker 3,000 European Speaker 4,000 American Speaker 5,000 Prizes for Outstanding Abstracts 3,000 Brochure Insert 2,000 All sponsorship and exhibition prices are subject to VAT I would like to book exhibition space: Sponsor Booth at 300 Euro per sq. meter Non-Sponsor booth at 700 per sq.m. (minimum booth size: 8 sq.m. 4x2 meters) Please call me to discuss the sponsorship package Please send me a sponsorship contract and first 50% deposit invoice. Signature: Date: 19

20 COGI 2009 Beijing Headquarters and Administration 53 Rothschild Boulevard PO Box 68, Tel Aviv, Israel Tel Fax Comtec Spain Bailén, 95-97, pral.1.a Barcelona, Spain Tel Fax Comtec China 175 Xiang Yang Road South, Shanghai , China Tel Fax